Sam Altman’s New Potential $367 Trillion Venture

CRM Earnings Wednesday. The Real Test Is Agentforce ARR.

Analyst Targets

• JPMorgan (Samik Chatterjee): Overweight, $250 target, sees core business accelerating in H2 FY27
• BMO Capital (Keith Bachman): Outperform, $230 target, raised from $215 on August 20
• Citi (Tyler Radke): Neutral, $204 target, raised from $187 on August 18, citing channel checks showing modest Agentforce improvement
• Morgan Stanley (Adam Wood): Equal Weight, $185 target, downgraded from Overweight on July 21, flagging a disconnect between AI momentum and subscription revenue growth
• Guggenheim: Buy, $228 target, upgraded from Neutral on July 1
• Consensus (S&P Global): Buy, average price target $243.98

Opening

Salesforce trades around $209 today. Two days from now it reports Q2 FY2027 results after the bell. That single event will either validate one of the most contested turnaround cases in software or hand the bears their fourth major sell-the-news episode of 2026.

Salesforce has surged into a strong rally this month, pushing shares to their highest level since February, now up about 43% from its 2026 low as it tracks the broader rebound in software names. The stock is simultaneously down substantially from its 52-week high of $269.11 and still wrestling with a sector identity crisis that erased trillions in software market value earlier this year.

The number that settles Wednesday’s debate is not revenue. It is not even adjusted EPS. It is Agentforce ARR, the one metric that determines whether Salesforce is genuinely converting AI promise into contracted revenue, or simply surviving on buyback math and government contract headlines while the underlying growth engine stalls.

Company Profile

Salesforce has held the number one CRM position for 13 consecutive years, according to IDC, and its remaining performance obligation stands at roughly $72 billion, a contracted revenue runway that exceeds its annual sales.

The company reported FY2026 total revenue of $41.5 billion, up 10% year over year, and holds 20.0% of the global CRM market, more than its four nearest competitors combined. Revenue flows from subscription and support contracts covering Sales Cloud, Service Cloud, Marketing Cloud, Commerce Cloud, Slack, and the Data 360 platform anchored by the Informatica acquisition. Professional services and training add a smaller but meaningful layer.

Salesforce frames itself as the platform helping organizations of any size become Agentic Enterprises, integrating humans, agents, apps, and data on a unified platform. That framing is the center of the 2026 investment debate.

The Numbers: What Analysts Expect Wednesday

• Revenue: Consensus calls for $3.27 in adjusted EPS on revenue of about $11.33 billion.
• Company guidance: Salesforce itself guided for second-quarter revenue of between $11.27 billion and $11.35 billion.
• Revenue segmentation: Salesforce now reports disaggregated revenue in two primary categories: Agentforce Apps, and Data 360, Headless Platform, & Other.
• RPO (Current): Salesforce reported current remaining performance obligation of $33.6 billion in Q1.
• Last quarter’s beat: Q1 FY2027 delivered adjusted EPS of $3.88 against a $3.13 consensus, with revenue of $11.13 billion growing 13.3% year over year, though the stock gave back its gains as investors focused on the free cash flow guidance reset tied to the $25 billion debt issuance for the accelerated share repurchase.

Why the Stock Is Moving Into This Report

Wall Street has increasingly referred to 2026’s sector-wide decline as a “SaaSpocalypse,” driven by concerns that AI agents and advanced coding tools may reduce dependence on legacy SaaS applications, and Salesforce shares had already fallen sharply in 2026 by late May.

The July recovery changed the tone without changing the underlying question. Citi analyst Tyler Radke raised his CRM price target to $204 citing channel checks showing modest improvement in Agentforce deployment, and the stock rose as much as 3.82% that day, extending a software-sector rotation that had taken CRM up nearly 15% over the prior month.

Seven weeks of upgrade calls, however, have each produced a pop and then given it back. JPMorgan’s Samik Chatterjee resumed coverage at Overweight with a $250 target on August 13, the loudest bullish call from a major bank since Guggenheim’s upgrade in early July. The pattern of 2026 says that analyst upgrades alone do not hold. Only the data moves this stock durably.

Two developments are shaping Wednesday’s context. The Army Human Resources Command selected Salesforce’s Missionforce National Security platform to deploy Agentforce, with deployment projected to serve 9.2 million soldiers, veterans, and families at an expected 55 million agent conversations per month at full scale. On the other side, The Information reported in August that the U.S. Department of Agriculture, which spends about $3 billion annually on IT and uses Salesforce for “pretty much everything,” is tapping C3 AI to reduce parts of its Salesforce footprint, complicating the “government signals universal confidence” thesis.

Agentforce: The Metric That Actually Matters

Agentforce ARR reached $1.2 billion in Q1 FY2027, up more than 200% year over year, with Salesforce delivering 3.8 billion agentic work units in the quarter.

The $25 billion accelerated share repurchase delivered approximately 103 million shares upfront, and a further $25 billion of authorization remains. The buyback is real and financially significant. But it is also a floor, not a catalyst. What moves the stock above $230 is ARR acceleration, not shrinking share counts.

The company is leaning heavily into AI, with Agentforce ARR above $1.2 billion, a stake in Anthropic that multiple reports have said is worth roughly $5 billion, and the m3ter deal aimed at supporting usage-based pricing for AI offerings. The shift from per-seat SaaS to consumption-based AI revenue is the structural transition investors are trying to underwrite.

Macro Context: The SaaSpocalypse Backdrop

Within 30 days in early 2026, approximately $2 trillion in market capitalization evaporated from enterprise software companies. The catalyst was not a recession or a regulatory event. It was AI agents, autonomous systems that began replacing the very software tools businesses had been paying for on a per-seat, per-month basis.

As the dust settles, many in the industry argue that AI will uplift SaaS as much as disrupt it. The critical distinction is between companies that own the workflow data and those that merely automate tasks on top of it. Enterprise platforms are fundamentally sticky given that they own the workflows, integrations, and increasingly the data. Salesforce sits in that category. The question is whether it can convert stickiness into growth acceleration before competitors close the Agentforce gap.

The Zacks consensus estimate for Salesforce’s fiscal 2027 revenues currently stands at $46.08 billion, indicating a year-over-year increase of approximately 11%. That estimate requires Agentforce ARR to keep compounding, not plateau.

Forward Scenarios

Bull Case

Agentforce ARR surpasses $1.8 billion in Q2, current RPO comes in above $34 billion signaling deal acceleration, and management raises full-year revenue guidance above the $46 billion consensus. The golden cross on the 50-day and 200-day weighted moving averages completes, shorts cover, and CRM tests $240 to $250 within weeks.

Base Case

Revenue lands inside the $11.27 to $11.35 billion guidance range with EPS modestly above the $3.27 consensus. Agentforce ARR grows to approximately $1.5 billion, consistent with recent trajectory. Management holds full-year guidance steady. The stock reacts positively but stalls near $215 to $220, the next clear resistance zone, as investors wait for Q3 evidence that Informatica cross-selling is genuinely accelerating the data layer.

Bear Case

Agentforce ARR growth decelerates materially from 200% to below 150%, current RPO disappoints against the $33.3 billion reference point, and management lowers or narrows full-year guidance. The USDA move toward C3 AI becomes a talking point on the call. Morgan Stanley’s Adam Wood cited the disconnect between AI momentum and subscription revenue growth when he downgraded to Equal Weight with an $185 target in July. That thesis returns with force, and CRM retests the $180 to $185 support band.

Technical Overlay

The daily chart shows CRM at a crucial resistance level near $210, which was also its high on June 1. The stock is forming a potential golden cross as the 50-day and 200-day weighted moving averages converge.

Resistance clusters at $206.87 and $215.04, with a clean break above either level signaling further upside. Support zones sit at $180.42 and $172.24, and a breakdown below either level would issue a meaningful sell signal.

CRM entered Monday’s session at $209.21, sitting above near-term moving average support after a strong August recovery. The stock has now reclaimed territory it lost in the June and July declines. A post-earnings move that holds above $210 on volume would represent the first sustained break of that level since winter. Anything that cracks $195 intraday suggests the gap lower is not filled.

What Investors Should Watch

• Agentforce ARR: The number that determines everything. Any print below $1.4 billion will disappoint. Above $1.8 billion triggers a re-rating.
• Current RPO: Contracted revenue visibility. Salesforce reported $33.6 billion in Q1. A miss here signals deal slowdown that EPS beats cannot offset.
• Free cash flow guidance: CRM generated $6.556 billion of free cash flow in Q1 alone. Any cut to full-year FCF guidance repeats the Q1 post-earnings fade.
• Informatica contribution clarity: Management needs to isolate organic ARR growth from Informatica-driven contribution. Investors are trying to determine how much of the 200%-plus ARR growth is platform-native versus acquisition-fueled.
• Guidance for H2: Management has expressed confidence in a path to reaccelerate organic revenue growth in H2 FY27. The Q2 guide-up or guide-down will determine whether that confidence is warranted.

Bottom Line

The upgrade cycle has failed Salesforce shareholders seven times in 2026. Analyst opinion is not the variable. Wednesday’s report is.

Salesforce is not a dying SaaS company. It holds 20% of the global CRM market with revenue more than four times greater than its nearest rival, Oracle. The moat is real. But the market is pricing something more specific: whether Agentforce is a genuine new revenue engine or a repackaging of existing functionality at inflated ARR math. The answer lives in the ARR acceleration rate and the current RPO trajectory, two numbers that Wednesday’s report will either confirm or collapse.

CRM at $209, with roughly $72 billion in contracted backlog and $25 billion in remaining buyback authorization, is not an expensive stock by historical measures. The discount exists because the market has not yet decided whether it is paying for a turnaround or a managed decline. Wednesday night is the moment where that question gets materially closer to an answer.

For informational purposes only.